Cargando…

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial

OBJECTIVE: To analyze the efficacy of gemcitabine with or without erlotinib for pancreatic cancer, and to determine the predictive role of epidermal growth factor receptor (EGFR) and KRAS mutations in these patients. METHODS: This was a single-center, randomized, open-label, prospective trial. Eight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jack P., Wu, Chen-Yi, Yeh, Yi-Cheng, Shyr, Yi-Ming, Wu, Ying-Ying, Kuo, Chen-Yu, Hung, Yi-Ping, Chen, Ming-Huang, Lee, Wei-Ping, Luo, Jiing-Chyuan, Chao, Yee, Li, Chung-Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627242/ https://www.ncbi.nlm.nih.gov/pubmed/26046796

Ejemplares similares

Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
por: Chou, Wen-Chi, et al.
Publicado: (2016)

Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017)

Erlotinib Plus Capecitabine as First-Line Treatment for Older Chinese Patients With Advanced Adenocarcinoma of the Lung (C-TONG0807): An Open-Label, Single Arm, Multicenter Phase II Study
por: Zhao, Hong-Yun, et al.
Publicado: (2015)

Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions
por: Shyr, Yi‐Ming, et al.
Publicado: (2021)

Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI
por: Chen, Yi-Fang, et al.
Publicado: (2017)

Learning curves for robotic pancreatic surgery-from distal pancreatectomy to pancreaticoduodenectomy
por: Shyr, Bor-Uei, et al.
Publicado: (2018)

Comparative study of the 7(th) and 8(th) AJCC editions for gastric cancer patients after curative surgery
por: Fang, Wen-Liang, et al.
Publicado: (2017)

Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection
por: Chang, Ya-Ting, et al.
Publicado: (2011)

Pancreatic groove cancer
por: Ku, Yuan-Hao, et al.
Publicado: (2017)

Endoscopic papillary balloon dilatation less than three minutes for biliary stone removal increases the risk of post-ERCP pancreatitis
por: Chou, Chung-Kai, et al.
Publicado: (2020)

Direct interaction of avermectin with epidermal growth factor receptor mediates the penetration resistance in Drosophila larvae
por: Chen, Li-Ping, et al.
Publicado: (2016)

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
por: Cardin, Dana B, et al.
Publicado: (2014)

Incidence of and Risk Factors for Tuberculosis (TB) in Gastric Cancer Patients in an Area Endemic for TB: A Nationwide Population-based Matched Cohort Study
por: Fang, Wen-Liang, et al.
Publicado: (2015)

Comparison of the surgical outcomes of minimally invasive and open surgery for octogenarian and older compared to younger gastric cancer patients: a retrospective cohort study
por: Liu, Chien-An, et al.
Publicado: (2017)

Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
por: Lan, Ming-Ying, et al.
Publicado: (2020)

Detection of Oral Dysplastic and Early Cancerous Lesions by Polarization-Sensitive Optical Coherence Tomography
por: Chen, Ping-Hsien, et al.
Publicado: (2020)

How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study
por: Wang, Jack P., et al.
Publicado: (2016)

Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study
por: Kuo, Yi-Ting, et al.
Publicado: (2017)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2)
por: Chan, Chien-Yi, et al.
Publicado: (2023)

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy
por: Wang, Chin-Chou, et al.
Publicado: (2021)

Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib
por: Wang, Xiaofei, et al.
Publicado: (2017)

A pilot study of lymph node mapping with indocyanine green in robotic gastrectomy for gastric cancer
por: Lan, Yuan-Tzu, et al.
Publicado: (2017)

Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
por: Tseng, Jeng-Sen, et al.
Publicado: (2014)

Primary Sjogren’s syndrome and the risk of acute pancreatitis: a nationwide cohort study
por: Chang, Chi-Ching, et al.
Publicado: (2017)

Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006)

Erlotinib in the treatment of advanced pancreatic cancer
por: Kelley, Robin K, et al.
Publicado: (2008)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives
por: Mao, Long-fei, et al.
Publicado: (2022)

Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib
por: Lee, Chia-Han, et al.
Publicado: (2022)

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
por: IWAI, TOSHIKI, et al.
Publicado: (2011)

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2022)

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
por: Kuo, Sung-Hsin, et al.
Publicado: (2023)

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study
por: Lee, Suey-Haur, et al.
Publicado: (2022)

Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer’s Disease Patients and Patients’ Adult Children
por: Huo, Chieh, et al.
Publicado: (2022)

Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment
por: Lin, Hung-Jun, et al.
Publicado: (2022)

Hepatoid carcinoma of the pancreas
por: Kuo, Po-Chung, et al.
Publicado: (2015)

The Clinicopathological Features and Genetic Alterations in Epstein–Barr Virus-Associated Gastric Cancer Patients after Curative Surgery
por: Fang, Wen-Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cbpk4ghlef56a3020rjkh3vpea